ISSN 2149-2263 | E-ISSN 2149-2271
Volume : 25 Issue : 12 Year : 2021
Quick Search



The Anatolian Journal of Cardiology Stereotactic ablative body radiotherapy for ventricular tachycardia: An alternative therapy for refractory patients [Anatol J Cardiol]
Anatol J Cardiol. 2021; 25(12): 858-862 | DOI: 10.5152/AnatolJCardiol.2021.187

Stereotactic ablative body radiotherapy for ventricular tachycardia: An alternative therapy for refractory patients

Carolina De La Pinta1, Raquel Besse2
1Department of Radiation Oncology, Ramón y Cajal Hospital; Madrid-Spain
2Department of Internal Medicine, Ramón y Cajal Hospital; Madrid-Spain

Stereotactic ablative body radiotherapy (SABR) allows the administration of ablative doses of radiation in a focused form with a low probability of side effects and is widely used for cancer treatment. However, in the recent years its usefulness in benign cardiac pathology is being studied. In this study, we aimed to guide the cardiologist in SABR and its applications in treatment of refractory ventricular tachycardia. In this review, we analyzed published literature on PubMed and MEDLINE with papers published in the past 5 years. We included papers in the English language with information about indications, radiotherapy plan, doses and fractionations, and outcomes. All citations were evaluated for relevant content and validation.

Keywords: stereotactic ablative body radiotherapy, radiosurgery, ventricular tachycardia, radiotherapy

Carolina De La Pinta, Raquel Besse. Stereotactic ablative body radiotherapy for ventricular tachycardia: An alternative therapy for refractory patients. Anatol J Cardiol. 2021; 25(12): 858-862

Corresponding Author: Carolina De La Pinta, Spain
Manuscript Language: English